ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Human Inhibin beta B Protein (N-terminal His Tag) (A63085)

$125

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 5-8 business days.
Name
Recombinant Human Inhibin beta B Protein (N-terminal His Tag)
Applications
SDS-PAGE
Expression System
Nicotiana benthamiana
Nature
Recombinant
Protein Species
Human
Protein Length
Protein fragment
Sequence
HHHHHHHHHH GLECDGRTNL CCRQQFFIDF RLIGWNDWII APTGYYGNYC EGSCPAYLAG VPGSASSFHT AVVNQYRMRG LNPGTVNSCC IPTKLSTMSM LYFDDEYNIV KRDVPNMIVE ECG
Tag
N-terminal His Tag
Predicted MW
14 kDa
Biologically Active
Yes
Biological Activity
The biological activity of Activin B is measured by its ability to inhibit mouse plasmacytoma cell line (MPC-11) cells proliferation. EC50 <5 ng/ml is required to stimulate a half-maximal response at cytokine saturation. Note: Since applications vary, each investigator should titrate the reagent to obtain optimal results.
Purity
>97% as determined by SDS-PAGE.
Product Form
Lyophilized
Concentration
1 mg/ml
Formulation
Lyophilized from 50 mM Tris HCl Buffer, pH 7.4.
Storage
Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.
Synonyms
Activin beta-B chain, INHBB, Inhibin beta B chain
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Human Inhibin beta B Protein (N-terminal His Tag) (A63085)? Please let us know so that we can list the citation on this page.

Alternative products to Recombinant Human Inhibin beta B Protein (N-terminal His Tag) (A63085)

Proteins predicted to interact with Inhibin beta B

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.1% Relevancy Score
98.7% Relevancy Score
98.6% Relevancy Score
98% Relevancy Score
97% Relevancy Score
94.8% Relevancy Score
94.1% Relevancy Score